Gene expression signatures predictive of bevacizumab/erlotinib therapeutic benefit in advanced non-squamous non-small cell lung cancer patients (SAKK 19/05 trial)
Franzini A, Zappa F, Klingbiel D, Grigoriu B, Betticher D, Droege C, Oliver D, Macovei I, Baty F, Brutsche M. Gene expression signatures predictive of bevacizumab/erlotinib therapeutic benefit in advanced non-squamous non-small cell lung cancer patients (SAKK 19/05 trial). Clin Cancer Res 2015
Apr 28, 2015
Gene expression signatures predictive of bevacizumab/erlotinib therapeutic benefit in advanced non-squamous non-small cell lung cancer patients (SAKK 19/05 trial)
Apr 28, 2015
Clin Cancer Res 2015
Franzini Anca, Zappa Francesco, Klingbiel Dirk, Grigoriu Bogdan D, Betticher Daniel, Droege Cornelia, Oliver Dürr, Macovei Ina I, Baty Florent, Brutsche Martin
more